See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.81▲ 0.20%Gold spot3,994▼ 0.75%WTI101.02▼ 2.18%
← 0A41 page
XStocksXray
Market X-Ray report · 23 October 2026

Gevo, Inc. (0A41)

London Exchange · UK · prices in USD · close of 23 Oct 2026

Key indicators

Last closeUSD 1.160
52-week range1.082 – 2.970
Return, 1 month / 3 months−21.1% / −37.3%
Return, 1 year / 3 years– / –
TrendBelow its 200-day average
RSI (14)30
Volatility (1 year)64.4%
Worst drawdown (1 year)-59.2%
Average daily value traded0.03M USD
Dividend yield–

Market X-Ray price-based

12/ 100 · Medium confidence · ahead of 3% of stocks on this exchange
Trend9
Momentum6
Stability (higher is calmer)15
Liquidity20
Income–

Five-year price chart navy: price · brown: 200-day average

1.031.491.952.412.872025-122026-022026-052026-082026-10

About the company

Gevo, Inc. is a renewable chemicals and biofuels company based in the United States. It develops and produces isobutanol and related products from renewable feedstocks such as corn and agricultural residues. These products serve fuel markets and industrial chemical applications, including solvents and plastics. The company also works on alcohol-to-jet fuel technology for aviation customers. Its activities span research, process development and production at its own facilities.

On this site Gevo, Inc. appears as a stock on the London Exchange (UK), code 0A41, with prices in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Gevo, Inc. (0A41) trades on the London Exchange in UK. It last closed at USD 1.160 on 23 October 2026.

Its price-based Market X-Ray is 12 out of 100 (a weak price profile), ranking 3,665 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Gevo, Inc. (0A41)

The five lenses in numbers each metric is ranked against the other stocks on London Exchange

Lens and metricValueScoreReading
Trend9 · WeakBelow its long-term averages and far from its highs.
Above 200-day average-33.2%
From 52-week high-58.2%
Momentum6 · WeakLagging most stocks on this exchange.
3-month return-37.3%
6-month return-35.9%
12-month return, skipping the last month–
Stability (higher is calmer)15 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)64.4%
Worst drawdown, 1 year (smaller is calmer)-59.2%
Liquidity20 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.03M USD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Trend: Below its long-term averages and far from its highs.
  • Momentum: Lagging most stocks on this exchange.
  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−0.9%
1 month−21.1%
3 months−37.3%
6 months−35.9%
1 year–
3 years–
5 years–

Signals

50-day / 200-day average1.454 / 1.737
Golden / death cross (60 days)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.076

Technical summary

DailyStrongly bearish1 bullish · 3 neutral · 11 bearish
WeeklyStrongly bearish0 bullish · 1 neutral · 6 bearish
MonthlyStrongly bearish0 bullish · 0 neutral · 1 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 26 Oct 2026